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Use of yeast artificial chromosomes (YACs) for studying control of
gene expression: Correct regulation of the genes of a human
,8-globin locus YAC following transfer to mouse erythroleukemia
cell lines
(developmental regulation/locus control region/DNase I sensitivity/somatic cell hybrids/gene transfer)
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ABSTRACT We demonstrate that transfer of a yeast ar-
tificial chromosome (YAC) containing 230 kb of the human
13globin locus into mouse erythroleukemia cells by fusion
results in correct developmental regulation of the human (-like
globin genes. Additionally, we show that early after hybrid
formation, human embryonic e- and fetal -globin genes are
coexpressed with the adult g3 gene but that after 10-20 weeks
in culture, globin gene expression switches to predominantly
adult. Thus, in contrast to shorter gene constructs, the globin
genes of the 3-globin locus YAC are regulated like the chro-
mosomal globin genes. These results indicate that transfer of
YACs into established cell lines can be used for the analysis of
the developmental control of multigenic and developmentally
regulated human loci.
Transfections of established cell lines with recombinant gene
constructs have been useful in identifying cis-acting regula-
tory elements. However, there have been size constraints on
how large a DNA sequence can be introduced into a cell by
existing methods. An ideal approach would be to introduce
an entire multigenic locus into a cell, thereby retaining the
proper spatial context of genes, flanking control regions, and
cis-acting sequences. In this work we show that normal
regulation of the globin genes of a 248-kb yeast artificial
chromosome (YAC) containing 230 kb of the human ,3globin
locus is established following transfer into mouse erythro-
leukemia (MEL) cells. Furthermore, the globin genes of the
YAC display a temporal switch from fetal y- to adult f-globin
expression and they respond to trans-acting stimuli that
activate the chromosomal 'y genes. Our findings imply that
transfer ofYACs into established cell lines can be used in the
analysis of the developmental control of multigene loci.
The functional genes of the human p locus are arrayed 5'
to 3' in the order in which they are expressed during devel-
opment, 5 Upstream of the E gene is the
locus control region (LCR), defined as a set offour erythroid-
specific and developmentally stable DNase I-hypersensitive
sites (designated 5' HS 1 to 5' HS 4) (1-3) that confer
high-level, copy number-dependent, integration site-
independent expression of globin genes in erythroid cells (3).
Another developmentally stable HS, termed 3' HS 1, is
present -z20 kb 3' to the 8 gene (1-3). Several cis control
sequences of the 8 locus have been identified by transfecting
recombinant globin gene constructs into cell lines, especially
The publication costs of this article were defrayed in part by page charge
payment. This article must therefore be hereby marked "advertisement"
in accordance with 18 U.S.C. §1734 solely to indicate this fact.
MEL cells. MEL cells express only adult murine globins at
low, but detectable levels and can be induced by a variety of
agents to terminally differentiate and produce high levels of
globin. MEL cells transfected with human p gene constructs
linked to the LCR or to individual HSs display high-level
expression of the human p-globin gene (4-6). When human
fetal globin genes are transferred into MEL cells, either alone
or in a 8-locus cosmid, they are inappropriately expressed
(7-10), indicating that perhaps sequences outside the trans-
fected DNA fragments are relevant to the developmental
regulation of fetal globin genes. In the experiments reported
here, we used a 248-kb YAC (11, 12) containing 230 kb of the
human ,-globin locus and flanking sequences; 82 kb comprise
the actual human ,-globin locus from 5' HS 4 to 3' HS 1, and
there are about 40 kb of additional sequence 5' to HS 4 and
about 110 kb 3' to the p globin gene.
MATERIALS AND METHODS
Hybrids were generated by fusion of G418-resistant, YAC-
containing murine L cells (adherent phenotype) with G418-
sensitive MEL cells (nonadherent phenotype). Approxi-
mately 5 x 106 MEL cells and 2.5 x 106 L cells were washed
free of serum, mixed, and centrifuged down in one pellet and
fused as described (13). After 48 hr of culture, nonadherent
cells were centrifuged and resuspended in fresh Iscove's
modified Dulbecco's medium with 20%o fetal bovine serum
and containing active G418 sulfate (Geneticin, GIBCO) at 0.9
mg/ml in a new tissue culture flask. Subsequently, every 2 or
3 days the nonadherent cells were poured into a new tissue
culture flask, in order to select for the nonadherent pheno-
type. Parental MEL cells were killed by the G418 and
parental L cells were removed each time the cells were
transferred into a new flask. After about 10 days to 2 weeks
in culture, clumps of vigorously growing cells were observed.
The cells were induced for 4 days in medium containing 2%
(vol/vol) dimethyl sulfoxide (Sigma). Globin assessment at
the protein level was accomplished by staining cell smears
with y- or -globin-specific monoclonal antibodies as de-
scribed (13).
Pulsed-field gel electrophoresis (PFGE) conditions were
1% SeaKem Gold agarose (FMC), 0.5x TBE, (lx is 89 mM
Abbreviations: YAC, yeast artificial chromosome; MEL, mouse
erythroleukemia cells; LCR, locus control region; HS, hypersensi-
tive site; PFGE, pulsed-field gel electrophoresis.
**To whom reprint requests should be addressed at: University of
Washington, Division of Medical Genetics RG-25, Seattle, WA
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FIG. 1. Fluorescence in situ hybridization of GyAyq4p8f cosmid
to L-MEL cell hybrids containing three copies (a and c) or one copy
(b and d) of a human f-globin locus YAC. (a and c) The arrows point
to the fluorescein signal resulting from hybridization of cosmid
cCH-1 to propidium iodide-stained metaphase chromosomes. (b and
d) Three distinct fluorescein signals (in b) and one signal (in d) are
observed in interphase nuclei.
Tris/89 mM boric acid/2 mM mM EDTA), 14°C, 24 hr, with
a 14-sec pulse time. Agarose plugs for PFGE analysis were
prepared from single-cell suspensions as described (12) and
DNA contained in plugs was digested with Sfi I. Southern
blots and hybridization were performed by standard methods
(14). For RNase protection, previously described techniques
and probes were used (15). For DNase I hypersensitivity
assays, aliquots of nuclei were digested at DNase I concen-
trations ranging from 0 to 5.0 ,ug/ml, in 0.5-,ug/ml increments
(16), and genomic DNA was digested with EcoRI. The probes
used in these assays are described in the legend of Fig. 2.
RESULTS
Transfer ofa j8-Globin Locus YAC intoMEL Ceils. To allow
selection of somatic cells containing the (3-locus YAC, a
neomycine-resistance gene conferring G418 resistance on
mammalian cells was introduced into the right arm ofpYAC4
vector sequence. Attempts to introduce the purified &3-YAC
directly into MEL cells by electroporation or microinjection
were unsuccessful. Therefore, we employed an alternative
strategy of first injecting the 3-YAC into mouse L cells and
then transferring the ,B-YAC-containing chromosome into
MEL cells by fusion. The YAC was introduced into the L-cell
line L A-9 by microinjection (12). PCR analysis showed that
the left and right vector-insert junctions were intact, RecA-
assisted restriction endonuclease cleavage showed that the
entire 230-kb insert was present, Sfi I digestion coupled with
PFGE and Southern blotting demonstrated the presence of a
140-kb Sfi I fragment encompassing the f-globin locus, and
other Southern blot analyses confirmed the presence of an
intact ff3globin gene (12).
To introduce the 3-YAC into MEL cells we transferred the
3-YAC-containing chromosome from the mouse L cells into
MEL cells by fusion. Two L-cell isolates (12), 1136, with a
single copy of the intact YAC, and I135, with three copies of
the intact YAC, were used for fusion with MEL lines 179 and










FIG. 2. Formation of LCR HSs. (a) Analysis of hybrid pool D
shows the formation of 5' HSs 1-4. (b) Analysis of the 1(36 L-cell line
shows the formation of a strong 5' HS 2, similar to that seen in hybrid
D. The expected locations of 5' HSs 3 and 4 are indicated but neither
was formed. A weak 5' HS 1 is present. (c) Map of the 3-globin LCR
showing the locations of the 5' HSs, EcoRI sites, and the probes used
in these experiments. EcoRI digestion yields a 10.4-kb fragment
containing 5' HSs 2-4 and a 6.5-kb fragment containing 5' HS 1.
Southern blot analysis utilized a 1.2-kb Bgl II-HindIII probe to
detect 5' HSs 2-4 (probe a). A 1.3-kb Sph I-Ssp I probe was used to
detect 5' HS 1 (probe b). E, EcoRI sites; P, parental band; M,
molecular size markers (kb). Arrows indicating increasing concen-
trations of DNase I from 0 to 5.0 jig/ml.
585. G418-resistant, nonadherent L-MEL hybrid cells were
collected; parental cells were selected against by their G418
sensitivity (MEL cells) or adherence (L cells). Four hybrid
pools, A and B (containing three copies of the YAC) and C
and D (containing one copy of the YAC) were produced. A
and C were products of fusion with MEL 179, while B and D
were from fusions with MEL 585. Sfi I digestion, PFGE, and
Southern blotting analysis demonstrated that the human
fglobin locus was intact (data not shown). Additional South-
ern blot analyses showed correct size fragments for the LCR,
the 6, Ay, and f3 genes, and the neomycin-resistance gene.
Thus, the hybrids contained intact (3-YAC sequences, in the
appropriate copy number.
To determine whether the three YAC inserts in hybrid B
were clustered at a single site or dispersed throughout the
genome, fluorescence in situ hybridization was performed (17)
with cosmid probe cCH-1, which contains 39 kb of the human
13globin locus from the Gy gene through the 8 gene. In all 50
metaphase cells scored from hybrid B, the signals from cosmid
cCH-1 were present on both chromatids of a single chromo-
some in each metaphase. Examination of hybrid B interphase
nuclei demonstrated three distinct hybridization signals in
close proximity, which is consistent with the presence ofthree
copies of the /3globin YAC in this cell line and suggests that
Proc. Natl. Acad. Sci. USA 90 (1993)
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these copies are arranged in tandem fashion (Fig. lb). As a
control we hybridized cosmid cCH-1 to interphase cells from
hybrid D; a single signal was found, consistent with a single
copy of the ,B-globin YAC in these cells (Fig. ld).
We examined the ability ofcharacteristic HSs in the human
(-globin LCR to form in the (-YAC-containing cell lines. As
shown in Fig. 2, the four HSs that are characteristic of the
LCR in erythroid cells, 5' HSs 1-4, were formed in L-MEL
hybrid pool D. When assayed in L-cell line 1,86, a strong 5'
HS 2 was demonstrated, similar to that observed in hybrid
pool D. The 5' HS 1 was formed but exhibited a decreased
sensitivity to DNase I digestion. The 5' HSs 3 and 4 were not
formed. Our results in the L-cell line are consistent with a
previous report (18). The formation of these HSs in line 1(36
is most likely related to the ability of the ,-YAC-containing
L-cell lines to transcribe the y and e-globin genes and, to a
lesser extent, the (-globin gene (Fig. 3 a and b).
Initial e-, -, and f-Globin Expression and Subsequent
Switch to Predominant (-Globin Expression from the Genes of
the (J-YAC. All hybrids maintained their erythroid cell phe-
notype as evidenced by their ability to terminally differentiate
after chemical induction with dimethyl sulfoxide [compare
lanes U (uninduced) and I (induced) of Fig. 3]. For analysis
of ,B-globin gene expression, 28 days after fusion, total RNA
was prepared from pellets of the cultured hybrid pools and
.: Hu
FIG. 3. Human globin expression in
HuE (126bp) 3-YAC L-MEL hybrids. Human (Hu)
-' or (- or mouse (Mo) a-globin mRNA
have protected fragments shown on the
right, along with the size of the protected
fragments in base pairs. Hybrids A and B
contain three copies of the (-YAC,
whereas C and D contain one copy. L3
and Ll are the I86 and I(5 ,-YAC L-cell
transfectants (12) used in the fusions.
Letters U and I indicate uninduced cells
and cells induced by dimethyl sulfoxide.
9 (205 bp) (a) Notice the presence of approximately
equal amounts of human vy and , mRNA
in all hybrids. There is predominantly
human y mRNA in Ll and L3 ,B-YAC
y(170bp) transfectants. (b) Presence of human E
mRNA in hybrids and L cells. (c) Human
globin gene expression in 12 single-cell
clones.
analyzed by RNase protection using human e, Ay, and , or
mouse a antisense RNAs as probes. All four hybrid pools
expressed human -, , and e-globin mRNAs (Fig. 3 a and
b). e gene expression was minor; the exposure time of the
autoradiograph shown in Fig. 3b was 2 weeks, in contrast to
an exposure time of 16 hr for the autoradiograph shown in
Fig. 3a. In all four pools, the y gene accounted for a
significant proportion ofhuman globin gene mRNA (Fig. 3a).
Thus, early after hybrid formation, the human globin genes
displayed fetal as well as adult globin expression in spite of
the adult environment of the MEL cell.
To examine whether the phenotype of the hybrids changed
over time, hybrid pools C and D (containing a single (-YAC)
were followed in culture for 17 weeks. Hybrid C switched off
y expression between 8 and 12 weeks (Fig. 4a). Hybrid D, in
which 50% of the human globin mRNA at 8 weeks was y,
expressed <5% 'ymRNA after 17 weeks in culture (Fig. 4a).
emRNA could not be detected after the sixth week in culture.
Staining the hybrids with fluorescent anti-y or anti-,B mono-
clonal antibodies showed that only rare cells were y-positive
after 3-4 months in culture (Fig. 5). These results indicated
that, in contrast to the globin gene fragments (7-9) or ,(locus
cosmids (ref. 10 and G.S., unpublished data) used before, the
globin genes of the (-locus YAC display correct develop-
mental regulation following transfer into MEL cells. The
a < QI
I3 I
I Hu3 (205 bp)
HuAX (I70 bp)
Mo ca (I 28 bp)
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FIG. 4. Globin gene switching in 3-YAC L-MEL hybrids. (a)
Switching during culture of hybrids C and D of Fig. 3a. (b) Switching
during culture of clones 6 and 8 of Fig. 3c.
human genes initially display a fetal-like globin program but
subsequently switch to adult globin expression, thus mim-
icking the in vivo developmental t-to-(3 switch.
Subcloning experiments were done to exclude the pos-
sibility that any changes in globin gene expression during
culture were due to a population selection artifact. Twelve
single-cell subclones were produced from hybrid pool D on
culture day 39 and were analyzed 2 weeks later. As shown
in Fig. 3c, there was heterogeneity in human globin expres-
sion among the subclones. Subclones 1 and 2 showed
predominantly , expression, subclones 3 and 4 predomi-
nantly y expression, and the remaining subclones displayed
approximately equal levels of 'y and 8 expression. Two of
these subclones, clone 6, which initially showed high (8
expression, and clone 8, which initially showed about equal
levels of y and 13 expression, were cultured for several
weeks (Fig. 4b). Clone 6 switched to exclusive,8 expression
between 8 and 16 weeks of culture, whereas clone 8
switched between 22 and 26 weeks in culture. Thus, as in
the parental hybrid, the hybrids of single-cell origin dis-
played a switch from y to (3 expression as culture time
advanced.
Response to Transactivation. To test whether the globin
genes of the YAC respond to transregulation, I,86 and 1I,5
cells were fused with GM979 cells, a MEL line which
coexpresses adult and embryonic globins and transactivates
the chromosomal human y-globin genes following fusion with
adult human lymphoblasts (19). Hybrid E of Fig. 6 contains
three copies of the 3-globin locus YAC, while hybrid F
contains one copy. Hybrid E expressed predominantly
y-globin [y/(y + 3) ratios ranged from 0.85 to 0.87] after 9-13
weeks in culture. There was predominant y-globin expression
in hybrid F after 12 and 16 weeks in culture [y/(y + (8) ratios
ranged from 0.89 to 0.97]. Thus, the genes ofthe (-locus YAC
displayed a predominant fetal globin expression program at a
time when their counterparts which had been transferred into
MEL cells had switched to predominant or exclusive adult
globin expression (Fig. 4). These results suggest that like the
chromosomal y genes (19), the y genes of the (-locus YAC
are responsive to the embryonic/fetal trans-acting environ-
ment of the GM979 erythroleukemia line.
FIG. 5. Cytocentrifuged smears ofinduced 3-YAC L-MEL hybrids were fixed and labeled with anti-y- and anti-,B-specific antibodies. Three
weeks after fusion ,B-YAC/MEL hybrids contain a high proportion of y (a) or ,3(c) globin-positive cells. Two-and-a-half months later y-globin
is present only in rare cells (b), whereas a large number of cells continue to express ,B-globin (d).
Proc. Natl. Acad. Sci. USA 90 (1993)
II


















FIG. 6. Human y- and 3-globin gene expression in 3-YAC
L-GM979 cell hybrids. Protected fragments and their sizes are as in
Fig. 3. E and F are hybrids containing three or one copy of the
3-YAC, respectively. U denotes uninduced cells; I denotes dimethyl
sulfoxide-induced cells. y.Globin gene expression predominates
over ,B-globin gene expression even after 3-4 months in culture. Hu,
human; Mo, mouse.
DISCUSSION
Analysis of the control of gene expression by the use of
transfer to established cell lines is based on the production of
recombinant constructs containing the genes of interest and
suspected regulatory sequences. This approach has allowed
delineation of several cis-acting sequences immediately
flanking the globin genes (reviewed in ref. 20). In the case of
multigenic loci or when regulatory elements are placed far
away from the structural genes, this approach creates prob-
lems, since size limitations in construct production constrain
the amount of sequence one can transfer, obliging one to
produce artificial recombinants by linking sequences nor-
mally located distant to the genes of a locus. During the
production of such recombinants, assumptions are made
about the importance of sequences that are omitted and about
the relevance of factors such as gene order or the distance
between genes and regulatory elements. For example, in the
case of the ,-globin locus, analysis of function of the LCR is
based on production of artificial constructs made by com-
bining LCR sequences with individual globin genes or with
cosmids containing several contiguous globin genes (4-6,
21-23). Even when large constructs are produced by ligation
of two cosmids (23), likely regulatory sequences such as the
3' HS 1 are omitted. Furthermore, no construct can accom-
modate the p-locus chromatin domain as defined by DNase
I sensitivity studies (1-3, 24). Our results, showing correct
developmental regulation of the globin genes of the p-locus
YAC, imply that transfer of plocus YACs into MEL cells can
be used for the analysis of regulatory elements of the p8 locus
without distorting normal chromosomal organization.
The finding that human e-, -y-, and p-globin transcription
occurs in the L cells prior to fusion with MEL cells suggests
that the fetal globin genes of the YAC are preactivated in the
L cells. This can explain the initial y and e gene expression
in the 8YAC L-MEL cell hybrids. However, subsequently
fetal gene expression switches off and there is only, or
predominantly, adult human globin gene expression. Such
temporal changes in expression are not observed when fetal
globin genes on smaller constructs are transferred into MEL
cells. Thus, when the Ay, 8, and 8 genes linked to an LCR
cassette on a cosmid construct are transferred to MEL cells,
the 'y gene is expressed at very high levels (ref. 10 and G.S.,
unpublished data) and there is no y--to-f3 switch during MEL
cell propagation in culture. The temporal switch ofthe globin
genes of the l3-YAC is thus similar to that observed in
neonatal cells. Also, as we show here, the transferred YAC
responds to trans stimuli after fusion with GM979 cells,
which contain fetal-like trans-acting elements. The , locus of
the YAC thus behaves distinctly differently than the gene
fragments, underscoring the importance of distant regulatory
elements on globin gene expression.
An implication of these results is that transfer of p-locus
YACs into MEL cells can be used for the analysis of
regulatory elements of the 8 locus without the distortion of
locus organization necessitated by the size constraints of
usual recombinant constructs. The system we describe here
may be applicable to the analysis of regulatory elements of
other multigenic loci or very large genes. YAC transfer into
differentiating cell lines of the proper lineages makes studies
of genes in their native environment an attractive alternative
to transfecting simple recombinant molecules into cells.
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